Celularity (CELU) Net Margin Growth (3y) (2023 - 2025)
Celularity (CELU) Net Margin Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Celularity | 20.73 Mn | 14.56 Mn | -3.27 Mn | -118,599.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -118,599.00 |
| Sep 30, 2025 | -55,272.00 |
| Jun 30, 2025 | -169,418.00 |
| Mar 31, 2025 | 88,586.00 |
| Dec 31, 2024 | -184,864.00 |
| Sep 30, 2024 | -64,333.00 |
| Jun 30, 2024 | 196,459.00 |
| Mar 31, 2024 | 291,379.00 |
| Dec 31, 2023 | 10,371.00 |
| Sep 30, 2023 | -109,878.00 |